Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacille Calmette-Guérin”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Looking for participantsNCT03888924
What this trial is testing

Bacille Calmette-Guérin (BCG) Vaccine In Radiologically Isolated Syndrome (RIS)

Who this might be right for
Multiple Sclerosis
S. Andrea Hospital 100
Early research (Phase 1)Study completedNCT01879163
What this trial is testing

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

Who this might be right for
Tuberculosis (TB)
University of Oxford 30
Not applicableUnknownNCT05820594
What this trial is testing

Using BCG Vaccine to Understand Tuberculosis Infection

Who this might be right for
Tuberculosis
Liverpool School of Tropical Medicine 30
Post-approval studies (Phase 4)Study completedNCT02447536
What this trial is testing

Trial of Two Strains of BCG

Who this might be right for
MorbidityBacille Calmette-Guérin
Bandim Health Project 12,006
Post-approval studies (Phase 4)Study completedNCT02953327
What this trial is testing

Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

Who this might be right for
Innate ImmunityBacille Calmette-Guérin
Bandim Health Project 40
Not applicableStudy completedNCT02380508
What this trial is testing

Heterologous Effects of BCG in Healthy UK Adults

Who this might be right for
Tuberculosis
University of Oxford 36
Not applicableStudy completedNCT01420705
What this trial is testing

Bacille Calmette-Guérin (BCG) Vaccine and Atopy

Who this might be right for
AsthmaEczemaFood Hypersensitivity
Bandim Health Project 487
Not applicableStudy completedNCT02444611
What this trial is testing

A Trial Investigating the Influence of BCG and Hepatitis B Immunisation at Birth on Neonatal Immune Responses: The Early Life Vaccines and Immunity Study

Who this might be right for
Innate Immune Response
Murdoch Childrens Research Institute 185
Post-approval studies (Phase 4)UnknownNCT04417335
What this trial is testing

Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination

Who this might be right for
COVID-19
Radboud University Medical Center 2,014
Large-scale testing (Phase 3)Study completedNCT01906853
What this trial is testing

Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction

Who this might be right for
AllergyEczemaRespiratory Tract Infections
Murdoch Childrens Research Institute 1,272
Testing effectiveness (Phase 2)UnknownNCT04922047
What this trial is testing

Safety and Efficacy Study of Tislelizumab in Combination With BCG in HR-NMIBC Patients (TACBIN-01)

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsUrogenital Neoplasms+3 more
RenJi Hospital 6
Post-approval studies (Phase 4)Study completedNCT01694108
What this trial is testing

Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children.

Who this might be right for
ProspectiveSingle-blindClinical+2 more
Lone Graff Stensballe 4,262
Testing effectiveness (Phase 2)Study completedNCT00462488
What this trial is testing

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Who this might be right for
Urinary Bladder CancerBladder CancerBladder Neoplasms+1 more
Sesen Bio, Inc. 46
Testing effectiveness (Phase 2)Ended earlyNCT02792192
What this trial is testing

Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 24